Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Yohann Loriot, Andrea Necchi, Se Hoon Park, Jesus Garcia-Donas, Robert Huddart, Earle Burgess, Mark Fleming, Arash Rezazadeh, Begoña Mellado, Sergey Varlamov, Monika Joshi, Ignacio Duran, Scott T. Tagawa, Yousef Zakharia, Bob Zhong, Kim Stuyckens, Ademi Santiago-Walker, Peter De Porre, Anne O’Hagan, Anjali Avadhani, Arlene O. Siefker-Radtke

Open source

DOI: 10.1056/nejmoa1817323
Published: 2019-07-25
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1817323,
  title = {Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma},
  author = {Yohann Loriot and Andrea Necchi and Se Hoon Park and Jesus Garcia-Donas and Robert Huddart and Earle Burgess and Mark Fleming and Arash Rezazadeh and Begoña Mellado and Sergey Varlamov and Monika Joshi and Ignacio Duran and Scott T. Tagawa and Yousef Zakharia and Bob Zhong and Kim Stuyckens and Ademi Santiago-Walker and Peter De Porre and Anne O’Hagan and Anjali Avadhani and Arlene O. Siefker-Radtke},
  year = {2019},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa1817323},
  url = {https://doi.org/10.1056/nejmoa1817323}
}

RIS

TY  - JOUR
TI  - Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
AU  - Yohann Loriot
AU  - Andrea Necchi
AU  - Se Hoon Park
AU  - Jesus Garcia-Donas
AU  - Robert Huddart
AU  - Earle Burgess
AU  - Mark Fleming
AU  - Arash Rezazadeh
AU  - Begoña Mellado
AU  - Sergey Varlamov
AU  - Monika Joshi
AU  - Ignacio Duran
AU  - Scott T. Tagawa
AU  - Yousef Zakharia
AU  - Bob Zhong
AU  - Kim Stuyckens
AU  - Ademi Santiago-Walker
AU  - Peter De Porre
AU  - Anne O’Hagan
AU  - Anjali Avadhani
AU  - Arlene O. Siefker-Radtke
PY  - 2019
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa1817323
UR  - https://doi.org/10.1056/nejmoa1817323
ER  -

APA

Loriot, Y., Necchi, A., Park, S. H., Garcia-Donas, J., Huddart, R., Burgess, E., Fleming, M., Rezazadeh, A., Mellado, B., Varlamov, S., Joshi, M., Duran, I., Tagawa, S. T., Zakharia, Y., Zhong, B., Stuyckens, K., Santiago-Walker, A., Porre, P. D., O’Hagan, A., Avadhani, A., & Siefker-Radtke, A. O. (2019). Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1817323

Source records

crossref · retrieved 2026-09-25T03:50:04.984Z